Chlamydia pneumoniae in multiple sclerosis: Humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker

Multiple Sclerosis

Volumn 7, Issue 1, 2001, Pages 13-18

  Krametter, D ^a   Niederwiese, G ^b   Berghold, A ^a   Birnbaum, G ^c   Strasser Fuchs, S ^a   Hartung, H P ^a   Archelos, J J ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^c Minneapolis Clinic of Neurology   (United States)

Author keywords

Antibody; Chlamydia pneumoniae; CSF; Multiple sclerosis; Serum

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION FUNCTION; DISABILITY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASES; CEREBROSPINAL FLUID PROTEINS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MEASLES VIRUS; MIDDLE AGED; MULTIPLE SCLEROSIS; MUMPS VIRUS; NERVOUS SYSTEM DISEASES; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 0035035432     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245801676514804     Document Type: Article

References (29)

1. Progress in determining the causes and treatment of multiple sclerosis
2. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS
3. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
4. Guillian-Barré syndrome after Chlamydia pneumoniae infection
5. Neurologic complications of chlamydial infections: Case report and review
6. Chlamydia pneumoniae associated with central nervous system infections
7. The virology of demyelinating diseases
8. Evidence for a viral etiology of multiple sclerosis
9. Concepts of viral pathogenesis in multiple sclerosis
10. Association between clinical disease activity and Epstein-Barr virus reactivation in MS
11. Pneumonia due to Chlamydia pneumoniae: Prevalence, clinical features, diagnosis, and treatment
12. The immunobiology and immunopathology of chlamydial infections
13. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
14. Chlamydia pneumoniae (TWAR)
15. The detection and significance of cerebrospinal fluid oligoclonal IgG
16. The role of B cells and autoantibodies in multiple sclerosis
17. Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis
18. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS
19. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis
20. Multiple sclerosis and Chlamydia pneumoniae
21. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
22. The use of serologic tests for the diagnosis of chlamydial infections
23. Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid
24. Multiple sclerosis cerebrospinal fluid
25. Flow rate of cerebrospinal fluid (CSF) - accept common to normal blood-CSF barrier function and to dysfunction in neurological diseases
26. The detection of intrathecal synthesis of anti-herpes simplex IgG antibodies: Comparison between an antigen-mediated immunoblotting technique and antibody index calculations
27. Chlamydia pneumoniae-specific humoral immune responses and clinical diseases parameters in multiple sclerosis
28. Chlamydia: A role for multiple sclerosis or more confusion?
29. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination